Morbidity and mortality in patient with an opioid use disorder and their children following treatment with a sustained release naltrexone preparation

    Research output: ThesisDoctoral Thesis

    206 Downloads (Pure)

    Abstract

    The aim of this thesis was to examine the safety of implant naltrexone in the treatment of non-pregnant and pregnant opioid dependent patients and their children.

    State and national health data were used to examine the health of patients treated with naltrexone, methadone and buprenorphine and the health of children who had been exposed to one of these opioid pharmacotherapies in utero.

    Rates of morbidity and mortality were largely comparable between implant naltrexone, methadone and buprenorphine treated patients. Rates of birth were significantly elevated in women treated with naltrexone, however maternal and child health outcomes were positive.
    Original languageEnglish
    QualificationDoctor of Philosophy
    Awarding Institution
    • The University of Western Australia
    Supervisors/Advisors
    • Hulse, Gary, Supervisor
    • Bennett, Kellie, Supervisor
    Award date13 Jun 2017
    DOIs
    Publication statusUnpublished - 2017

    Fingerprint

    Dive into the research topics of 'Morbidity and mortality in patient with an opioid use disorder and their children following treatment with a sustained release naltrexone preparation'. Together they form a unique fingerprint.

    Cite this